Propanc Biopharma (NASDAQ Uplisting) (PPCB) Plans to Raise $5 Million in June 27th IPO
Propanc Biopharma (NASDAQ Uplisting) (PPCB) expects to raise $5 million in an initial public offering (IPO) on Friday, June 27th, IPO Scoop reports. The company plans to issue 1,000,000 shares at $4.00-$6.00 per share. Propanc Biopharma (NASDAQ Uplisting) has a market cap of $65.6 million. D. Boral Capital (ex-EF Hutton) and Craft Capital acted as […]
Propanc Biopharma (NASDAQ Uplisting) (PPCB) expects to raise $5 million in an initial public offering (IPO) on Friday, June 27th, IPO Scoop reports. The company plans to issue 1,000,000 shares at $4.00-$6.00 per share. Propanc Biopharma (NASDAQ Uplisting) has a market cap of $65.6 million. D. Boral Capital (ex-EF Hutton) and Craft Capital acted as […]
